Disopyramide Sustained-Release Capsules and Zevalin Y-90
Determining the interaction of Disopyramide Sustained-Release Capsules and Zevalin Y-90 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Y-90 Zevalin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Sustained-Release Capsules-Zflex
- Disopyramide Sustained-Release Capsules-Zgesic
- Disopyramide Sustained-Release Capsules-Ziac
- Disopyramide Sustained-Release Capsules-Ziagen
- Disopyramide Sustained-Release Capsules-Ziagen (Abacavir Oral Solution)
- Disopyramide Sustained-Release Capsules-Ziagen (Abacavir Tablets)
- Zevalin Y-90-DisperMox
- Zevalin Y-90-Disposable Enema rectal
- Zevalin Y-90-Disulfiram
- Zevalin Y-90-Dithol Solution
- Zevalin Y-90-Ditropan
- Zevalin Y-90-Ditropan XL